Events

EARMA and INORMS conference - a Sustainable profession in a sustainable world
MAY
Tue
06
MAY
Wed
07
MAY
Thu
08

This was 8 months ago

Location

FEMA Palacio Municipal, MAdrid, Spain

Programmes
Horizon Europe

The European Association of Research Managers and Administrators (EARMA) will host the next congress of  INORMS , the International Network of Research Management Societies.

More information is published on the EARMA event page

The conference theme is "a sustainable profession in a sustainable world". 

Following topics will be addressed:
       πŸ”· Building Better RMA Services
       πŸ”· Governance and Regulation
       πŸ”· Knowledge Valorisation
       πŸ”· Open Science
       πŸ”· Proposal, Award, and Project Management
       πŸ”· Responsible Use of AI in Research Management
       πŸ”· Transnational Collaborations
       πŸ”· Sustainability in RMA
       πŸ”· Responsibility, Ethics, and EDI in Research and Innovation

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.